These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24535562)

  • 21. [Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China].
    Liu Y; Zhong SL; Yang M; Tan HH; Fei HW; Chen JY; Yu XY; Lin SG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):798-803. PubMed ID: 22178823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.
    Hadjipanagi D; Chrysanthou S; Voskarides K; Deltas C
    BMC Res Notes; 2014 Mar; 7():123. PubMed ID: 24593903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639GKaur A; Khan F; Agrawal SS; Kapoor A; Agarwal SK; Phadke SR
    Indian J Med Res; 2013 Jan; 137(1):203-9. PubMed ID: 23481074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
    Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
    Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.
    Ye C; Jin H; Zhang R; Sun Y; Wang Z; Sun W; Sun W; Peng Q; Liu R; Huang Y
    J Int Med Res; 2014 Feb; 42(1):67-76. PubMed ID: 24287930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol.
    Sehgal T; Hira JK; Ahluwalia J; Das R; Vijayvergiya R; Rana SS; Varma N
    Drug Discov Ther; 2015 Dec; 9(6):404-10. PubMed ID: 26781925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin K epoxide reductase complex 1 (VKORC1) gene polymorphisms in population of Eastern Croatia.
    Mandić D; Mandić S; Horvat V; Samardzija M; Samardzija M
    Coll Antropol; 2013 Dec; 37(4):1321-6. PubMed ID: 24611351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].
    Cui GL; Ding H; Xu YJ; Chen C; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):477-81. PubMed ID: 22943641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of VKORC1 and CYP2C9 variants on dosage of oral anticoagulants in Chilean individuals].
    Benavides F; Grossman N; Poggi H; Nieto E; Bertrán A; Araos D; Vásquez M; Ibarra I; Cáceres F; Espinoza K; Lagos M; Repetto M G
    Rev Med Chil; 2015 Nov; 143(11):1369-76. PubMed ID: 26757860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population.
    Djaffar-Jureidini I; Chamseddine N; Keleshian S; Naoufal R; Zahed L; Hakime N
    Genet Test Mol Biomarkers; 2011 Nov; 15(11):827-30. PubMed ID: 21651319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement.
    Demir HD; Ortak H; Şahin Ş; Ateş Ö; Benli I; İnanır A
    Ophthalmic Genet; 2014 Mar; 35(1):7-11. PubMed ID: 23362849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between VKORC1 single nucleotide polymorphism 1173C>T, bone mineral density & carotid intima-media thickness.
    Fodor D; Bondor C; Albu A; Popp R; Pop IV; Poanta L
    Indian J Med Res; 2013 Apr; 137(4):734-41. PubMed ID: 23703341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.
    Scott SA; Edelmann L; Kornreich R; Desnick RJ
    Am J Hum Genet; 2008 Feb; 82(2):495-500. PubMed ID: 18252229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes.
    Zhu Y; Shennan M; Reynolds KK; Johnson NA; Herrnberger MR; Valdes R; Linder MW
    Clin Chem; 2007 Jul; 53(7):1199-205. PubMed ID: 17510308
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Osman NA; El-Abd N; Nasrallah M
    Saudi J Kidney Dis Transpl; 2016; 27(5):908-915. PubMed ID: 27751997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of CYP2C9 and VKORC1 risk alleles for warfarin sensitivity and resistance in the Israeli population.
    Efrati E; Elkin H; Sprecher E; Krivoy N
    Curr Drug Saf; 2010 Jul; 5(3):190-3. PubMed ID: 20210733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.
    Saito R; Takeda K; Yamamoto K; Nakagawa A; Aoki H; Fujibayashi K; Wakasa M; Motoyama A; Iwadare M; Ishida R; Fujioka N; Tsuchiya T; Akao H; Kawai Y; Kitayama M; Kajinami K
    J Thromb Thrombolysis; 2014 Jul; 38(1):105-14. PubMed ID: 23928870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia.
    Alzahrani AM; Ragia G; Hanieh H; Manolopoulos VG
    Biomed Res Int; 2013; 2013():315980. PubMed ID: 23586031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between polymorphisms of VKORC1 and CYP2C9 genes with warfarin maintenance dose in a group of warfarin users in Birjand city, Iran.
    Fereidouni M; Moossavi M; Kazemi T; Nouranihassankiade S; Asghari A
    J Cell Biochem; 2019 Jun; 120(6):9588-9593. PubMed ID: 30525241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.
    Borgiani P; Ciccacci C; Forte V; Romano S; Federici G; Novelli G
    Pharmacogenomics; 2007 Nov; 8(11):1545-50. PubMed ID: 18034619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.